Research and Markets: Point-of-Delivery Drug, Reconstitution Systems Markets, Strategies and Prospects


Research and Markets ( has announced the addition of the "Point-of-Delivery Drug, Reconstitution Systems Markets, Strategies and Prospects" report to their offering.

Growth in the number of injectable drugs supplied in solid form for reconstitution prior to administration is being driven by the increase in drugs based on biological NCEs. These drugs are typically unstable at ambient temperatures and to preserve their shelf life must be either stored at low temperature (the so-call 'cold chain') or processed into a form that will preserve their pharmacological efficacy until they reach their therapeutic destination.

Because the cost of transporting and storing drugs using refrigeration is expensive and requires constant temperature monitoring to insure that the drug has not been exposed to environmental conditions that render unsafe for use as a therapeutic product, technologies such as lyophilization are becoming more prevalent.

The packaging and technologies developed and marketed for safe and reliable reconstitution at the point of administration are benefiting from this market trend. This report examines commercial drug reconstitution devices and systems and their impact on the injectable drug delivery sector.


- Analyzes therapeutic demand drivers and evaluates the market impact and potential of commercial drug reconstitution systems

- Provides analysis of injectable drugs for reconstitution and assesses key market segments, market dynamics and market demographics

- Forecasts Injectable drug product demand by indication and therapy to 2017

-Profiles reconstitution system suppliers, their product activities, business strategies, and corporate alliances and affiliations

Topics Covered

Executive Summary

Market Dynamics

Prolonging the Shelf Life of Biological Drugs

Distribution Strategies

Formulation Strategies

Lyophilization and Reconstitution at the Point of Use

Healthcare Economics and Reconstitution Systems

What's Driving the Growth in Engineered Reconstitution Systems?

Biological Drugs Proliferating

The Trend toward Self-Administration

Shifting Demographics

Innovation in Disposable Device Designs

Therapeutic Demand Drivers

Competitive Landscape

Risk Factors

Drug Reconstitution Systems - Commercial Devices

Vial Adapters

Vial-to-Vial Systems

Needle-less Transfer Devices

Direct Connect to Vial

Direct Connect to Cartridge

Dual Chamber Syringes

Dual Chamber Cartridges

Closed Drug Transfer

Reconstitution System Design Factors

Stability and Material Selection Issues

Disposable Drug Cartridges

Single vs Multi-Dose Devices

Human Engineering/Ergonomics

Drug Reconstitution - Therapeutic Sector Analysis

Market Factors

Drug Reconstitution Systems - Company Profiles

For more information visit

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

Posted In: Press Releases